Skandinaviska Enskilda Banken (SEB)
UROV

Skandinaviska Enskilda Banken (SEB)’s Urovant Sciences Ltd. UROV Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio UROV Stock Details UROV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-46,299
Closed -$745K – 1230
2020
Q4 		$745K Buy
+46,299
New +$574K 0.01% 860

Skandinaviska Enskilda Banken (SEB)'s UROV Position: Q1 2021 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Urovant Sciences Ltd. (UROV) in Q1 2021, closing a stake of 46,299 shares — an estimated $745K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in UROV in Q4 2020 and held it in 1 quarter. The position peaked at $745K in Q4 2020. 0 funds tracked by Wall St. Rank hold UROV as of Q1 2021.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Urovant Sciences Ltd. position as of Q1 2021 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 46,299 Urovant Sciences Ltd. shares in Q1 2021, an estimated $745K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Urovant Sciences Ltd. in Q4 2020 and held it in 1 quarter.
  • Skandinaviska Enskilda Banken (SEB)'s Urovant Sciences Ltd. position peaked at $745K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Urovant Sciences Ltd. as of Q1 2021.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2021, filed 14 May 2021.